摘要
CD19抗原作为B细胞谱系标志物,在部分急性髓系白血病患者的细胞上也表达,但对其预后情况尚存在较大争议。因此,文章主要介绍CD19在急性髓系白血病中的表达,并对其预后进行探讨,为此类型白血病的诊断和治疗提供一定的依据。
CD19 antigen,as a B-cell lineage marker,is also expressed in some cells of patients with acute myeloid leukemia,but its prognosis is still controversial.Therefore,this article mainly introduces the expression of CD19 in acute myeloid leukemia and discusses its prognosis,so as to provide a certain basis for future diagnosis and treatment.
作者
白会恩
闫理想
林旭(综述)
史哲新(审校)
Bai Huien;Yan Lixiang;Lin Xu;Shi Zhexin(The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300381,China)
出处
《疑难病杂志》
CAS
2023年第4期441-444,共4页
Chinese Journal of Difficult and Complicated Cases
基金
天津市教委科研计划项目(2021KJ145)。
